r.rathi@medgatetoday.com
India’s first indigenous vaccine against COVID-19, Covaxin, is safe and generates immune response without any serious side effects, according to the interim results of
Despite the rise in COVID-19 cases, the situation in Mumbai is under control and there is no immediate need to impose a lockdown in
Till now no “major report of discordant test results” has been reported by COVID-19 testing laboratories, Minister of State for Health Ashwini Choubey told
India has been at the forefront in fighting the coronavirus pandemic and “really stands out” in terms of its vaccine policy, Chief Economist of
The COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according
A technical committee of experts in Mexico gave a unanimous favorable opinion Friday on approving the COVAXIN vaccine made by the Indian pharmaceutical company
The production of coronavirus vaccines and scaling up global availability could be seriously limited due to ban on exports of critical raw materials by
Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, on Friday announced the first interim analysis of its BBV152 (COVAXIN®).
Modified vaccines to protect against new variants of coronavirus can be fast-tracked through the approval system, the UK’s independent medicines regulator said on Thursday. The
Japan’s government will extend a state of emergency in the Tokyo region for another two weeks because its medical systems are still strained by